pharmaceuticals

The top three pharmacy challenges of 2018
The top three pharmacy challenges of 2018Find out what challenges top the list, and what analysts say can be done about them.
Specialty Pharmacy Will Gain a Bigger Chunk of U.S. PharmaceuticalsThe specialty explosion is only going to get bigger.
Pediatric drug market poised for growthMore support for clinical trials and a wider lens for rare diseases in children sets the category on fire.
Helpful tips for using pharmaceuticals with kidsChildren are not little adults, and it’s only common sense to be aware of a child’s age and weight when dosing pharmaceuticals. Here are some other helpful gems I’ve uncovered about medications.
Three ways technology is improving pharmacyTechnology advances in pharmacy include innovations that improve medication safety, efficiency, and patient compliance.
Incremental clinical advances for Duchenne Muscular DystrophyJust last year, the FDA approved Exondys 51 (eteplirsen) for DMD, over the recommendations of FDA scientists and an external scientific advisory committee. Read more.
Will Trump follow through with an ACA repeal?In this commentary, Gerard J. Wedig of Simon Business School discusses the many possible implications of a Trump presidency.
Four things health execs should know about the oncology pipeline
Four things health execs should know about the oncology pipelineHere’s how you can recognize changes in the oncology pipeline and maximize value related to cancer care.
Drug pipeline developments: Alopecia areata and atopic dermatitisPromising treatments are coming for alopecia areata and atopic dermatitis, but they will come at a high cost.
Managed care pharmacy survey findings 2016To identify the top managed care pharmacy challenges and what your peers are doing about them, Managed Healthcare Executive, in partnership with Access Market Intelligence and the National Institute of Collaborative Healthcare, conducted its first-ever pharmacy survey during the second quarter of 2016.